Search

The removal control of radioactive aerosols in a nuclear emergency is an important issue, and capture fixation is a parameter for studying the purification effect of aerosol fixatives on aerosols. Herein, PAM-g-PAA, PAM-g-PHEA, and PAM-g-PAA/PHEA were obtained by chemical grafting with polyacrylamide as the substrate, acrylic acid and 2-hydroxyethyl acrylate as grafting monomers. The grafting product was confirmed by infrared spectroscopy and the grafting rate was calculated. The microstructure of different products were compared and discussed by scanning electron microscope images of freeze-drying and film formation. The capture and sedimentation effects of tellurium (simulated polonium) aerosol were studied by surface tension and fixed sedimentation experiments (PAM, PAM-g-PAA, PAM-g-PHEA, PAM-g-PAA/PHEA aqueous solution), and the mechanism of aerosol fixation was discussed. The results showed that the surface tension of the grafted product was significantly lower than that of the substrate PAM. Among them, the aerosol fixing agent PAM-g-PHEA grafted with HEA modified polyacrylamide can more effectively capture and fix tellurium aerosol particles, and its fixed sedimentation efficiency is 94.34%, which provides a research idea for the purification of polonium radioactive aerosol by atomization fixation method.

Microspherical structures find broad application in chemistry and materials science, including in separations and purifications, energy storage and conversion, organic and biocatalysis, and as artificial and bioactive scaffolds. Despite this utility, the systematic diversification of their morphology and function remains hindered by the limited range of their molecular building blocks. Drawing upon the design principles of reticular synthesis, where diverse organic molecules generate varied porous frameworks, we show herein how analogous microspherical structures can be generated under mild conditions. The assembly of simple organic molecules into microspherical structures with advanced morphologies represents a grand challenge. Beginning with a partially condensed Schiff base which self-assembles into a hierarchical organic microsphere, we systematically synthesized sixteen microspheres from diverse molecular building blocks. We subsequently explicate the mechanism of hierarchical assembly through which these hierarchical organic microspheres are produced, isolating the initial monomer, intermediate substructures, and eventual microspheres. Furthermore, the open cavities present on the surfaces of these constructs provided distinctive adsorptive properties, which we harnessed for the immobilization of enzymes and bacteriophages. Holistically, these hierarchical organic microspheres provide an approach for designing multi-functional superstructures with advanced morphologies derived from simple organic molecules, revealing an extended length scale for reticular synthesis. Microspherical structures are broadly applicable, but their morphology and function is limited by the molecular building blocks available. Here, the authors describe the selfassembly process of condensed Schiff bases into multifunctional hierarchical organic microspheres.' [ABSTRACT FROM AUTHOR]

Background: The usefulness of postoperative adjuvant chemotherapy (ACT) for patients with stage I lung adenocarcinoma with micropapillary (MIP) components remains unclear. We analyzed whether postoperative ACT could reduce recurrence in patients with stage I lung adenocarcinoma with MIP components, thereby improving their overall survival (OS) and disease‐free survival (DFS). Methods: Data for patients with pathologically confirmed stage I lung adenocarcinoma with MIP components from January 2012 to December 2018 were retrospectively analyzed. OS and DFS were analyzed in groups and subgroups. Results: Overall, 259 patients were enrolled. Patients who received ACT in stage IA showed significantly better survival than did those with no‐adjuvant chemotherapy (NACT); (5‐year OS 89.4% vs. 73.6%, p < 0.001; 5‐year DFS 87.2% vs. 66.0%, p = 0.008). A difference was also observed for in‐stage IB patients (5‐year OS 82.0% vs. 51.8%, p = 0.001; 5‐year DFS 76.0% vs. 41.11 %, p = 0.004). In subgroup analysis based on the proportion of MIP components, patients with 1%–5% MIP components had a significantly better prognosis in the ACT group than in the NACT group (5‐year OS 82.4% vs. 66.0%, p = 0.005; 5‐year DFS 76.5% vs. 49.1%, p = 0.032). A similar difference was observed for patients with MIP ≥5% (5‐year OS 80.7% vs. 47.8%, p = 0.009; 5‐year DFS 73.11% vs. 43.5%, p = 0.007). Conclusion: Among patients with stage I lung adenocarcinoma with MIP components, those who received ACT showed significant survival benefits compared to those without ACT. Patients with lung adenocarcinoma with MIP components could benefit from ACT when the MIP was ≥1%. The need for patients with Stage I lung adenocarcinoma containing micropapillary (MIP) components to receive adjuvant therapy after surgery is unclear. The results of this study suggest that the presence of MIP components is a significant risk factor for poor prognosis. We found that in patients with Stage I lung adenocarcinoma with MIP components, those who received adjuvant chemotherapy showed significant survival benefits. [ABSTRACT FROM AUTHOR]

BackgroundStrippable and self-brittle decontaminants are the two most commonly used surface decontaminants. However, peelable decontaminants have problems such as poor mechanical properties and difficulty in peeling whilst the self-brittle decontaminants become brittle due to the diaphragm and cause the potential of secondary pollution during the curing process.PurposeThis study aims to prepare several surface radiaction decontaminants and analyze their performance of decontamination.MethodsFirst of all, butyl acrylate (BA), methacrylic acid (MAA), methyl methacrylate (MMA), acrylic acid (AA) were selected, and preemulsion polymerization was adopted. Two kinds of surface decontaminants with different curing morphology were prepared. Then, the mechanical properties were tested by electronic universal testing machine and the surface of the membrane was observed by optical microscope, and simulated cold decontamination rate test was carried out according to IAEA recommended steps. Finally, action mechanism of surface radioactive decontaminant was studied by wettability and zeta potential test, as well as the combination of detergent and pollutants.ResultsThe test results for BA, MMA, and AA show that the good physical and mechanical properties is achieved when mBA:mMMA:mAA=1:0.9:0.1 hereby the tensile strength can be up to 9.16 MPa and the breaking elongation can be up to 671%, which is a good peeling detergent substrate. Particle size control of MAA and MMA can control the solidification morphology of decontaminant.ConclusionsThe two detergents can be completely excreted and embrittled on different surfaces and forms, and the decontamination rate of simulated nuclides can reach more than 90%.

Objective: Whether to continue administering immunotherapy to patients with advanced non-small cell lung cancer (NSCLC) who have experienced tumor progression remains controversial after immunotherapy. The aims were to explore survival outcomes after further immunotherapy post-progression and to determine the optimal combination therapy in such cases., Methods: Overall, 507 patients with NSCLC who underwent immunotherapy and experienced tumor progression were retrospectively divided into Immuno-combination and No-immuno groups according to whether additional combination therapy involving immunotherapy was administered post-progression. Progression-free survival (PFS) and overall survival (OS) were evaluated. Subgroup analyses were performed according to the different treatment regimens for patients in the Immuno-combination group., Results: After propensity score matching, there were 150 patients in the No-immuno group and 300 patients in the Immuno combination group. Superior PFS was observed in the Immuno-combination group compared with those in the No-immuno group (6-month PFS: 25.3 % vs. 60.6 %; 12-month PFS: 6.7 % vs. 24.4 %; P < 0.001). Similar intergroup differences were observed for OS (12-month OS: 22.3 % vs. 69.4 %; 18-month OS: 6.4 % vs. 40.4 %; P < 0.001). Superior PFS outcomes were observed in the Immuno+Antiangiogenic group compared with the Immuno+Chemo group (6-month PFS: 51.3 % vs. 71.5 %; 12-month PFS: 23.1 % vs. 25.7 %; P = 0.017). Similar differences in OS were observed between those same subgroups (12-month OS: 62.1 % vs. 77.9 %; 18-month OS: 33.3 % vs. 48.7 %; P = 0.006)., Conclusion: Patients with NSCLC experiencing tumor progression post-immunotherapy can still benefit from further treatment, with immunotherapy combined with antiangiogenic therapy the most efficacious option., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier Inc.)

Immune checkpoint inhibitors (ICIs), a novel anti-tumor therapeutic modality, are monoclonal antibodies targeting certain immune checkpoints (ICs) that reactivate T cells to achieve anti-tumor immunity by targeting, binding, and blocking ICs. Targeted inhibitory antibodies against the ICs cytotoxic T-lymphocyte antigen and programmed death receptor-1 have demonstrated efficacy and durable anti-tumor activity in patients with cancer. ICs may prevent autoimmune reactions. However, ICIs may disrupt ICs properties and trigger autoimmune-related adverse reactions involving various organ systems including the cardiovascular, pulmonary, gastrointestinal, renal, musculoskeletal, dermal, and endocrine systems. Approximately 10% of patients with damage to target organs such as the thyroid, pituitary, pancreas, and adrenal glands develop endocrine system immune-related adverse events (irAEs) such as thyroid dysfunction, pituitary gland inflammation, diabetes mellitus, and primary adrenal insufficiency. However, the symptoms of immunotherapy-associated endocrine system irAEs may be nonspecific and similar to those of other treatment-related adverse reactions, and failure to recognize them early may lead to death. Timely detection and treatment of immunotherapy-associated endocrine irAEs is essential to improve the efficacy of immunotherapy, prognosis, and the quality of life of patients. This study aimed to review the mechanisms by which ICIs cause endocrine irAEs providing guidance for the development of appropriate management protocols. Here, we discuss (1) the biological mechanisms of ICs in tumorigenesis and progression, focusing on cytotoxic T-lymphocyte antigen and programmed cell death-1/programmed cell death-ligand 1; and (2) the epidemiology, clinical symptoms, diagnosis, and treatment of four immunotherapy-related endocrine complications., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Authors.)

High blood glucose has long been established as a risk factor for tumor metastasis, yet the molecular mechanisms underlying this association have not been elucidated. Here we describe that hyperglycemia promotes tumor metastasis via increased platelet activity. Administration of glucose, but not fructose, reprogrammed the metabolism of megakaryocytes to indirectly prime platelets into a prometastatic phenotype with increased adherence to tumor cells. In megakaryocytes, a glucose metabolism-related gene array identified the mitochondrial molecular chaperone glucose-regulated protein 75 (GRP75) as a trigger for platelet activation and aggregation by stimulating the Ca 2+ -PKCα pathway. Genetic depletion of Glut1 in megakaryocytes blocked MYC-induced GRP75 expression. Pharmacologic blockade of platelet GRP75 compromised tumor-induced platelet activation and reduced metastasis. Moreover, in a pilot clinical study, drinking a 5% glucose solution elevated platelet GRP75 expression and activated platelets in healthy volunteers. Platelets from these volunteers promoted tumor metastasis in a platelet-adoptive transfer mouse model. Together, under hyperglycemic conditions, MYC-induced upregulation of GRP75 in megakaryocytes increases platelet activation via the Ca 2+ -PKCα pathway to promote cancer metastasis, providing a potential new therapeutic target for preventing metastasis. SIGNIFICANCE: This study provides mechanistic insights into a glucose-megakaryocyte-platelet axis that promotes metastasis and proposes an antimetastatic therapeutic approach by targeting the mitochondrial protein GRP75., (©2021 American Association for Cancer Research.)